Literature DB >> 19494714

Detection of small bowel tumors by videocapsule endoscopy in patients with acromegaly.

C L Ronchi1, F Coletti, E Fesce, L Montefusco, C Ogliari, E Verrua, P Epaminonda, E Ferrante, E Malchiodi, V Morelli, P Beck-Peccoz, M Arosio.   

Abstract

The prevalence of colon polyposis andmalignancies is increased in acromegalic patients as compared to the general population. An epidemiological study suggests a high prevalence also of small bowel (SB) tumors that nowadays may be detected by videocapsule endoscopy (VCE). The aim of the study was to assess the prevalence of SB neoplasms using VCE in acromegalic patients in comparison to control subjects and to correlate it with cancer risk factors and acromegaly-related parameters. Eighteen acromegalic patients (6 males and 12 females, age+/-SD: 54+/-10 yr), 5 cured after surgery (followed by radiotherapy in 3 cases) and 13 on pharmacological treatment were enrolled, and 36 sex- and age-matched non-acromegalic subjects served as a control group. Cancer risk factors, duration of acromegaly, GH and IGF-I levels, IGF binding protein 3 and IGF-II concentrations, metabolic parameters, tumor markers, colonic lesions by total colonoscopy, and SB lesions by VCE were investigated. VCE images suggestive of SB lesions were detected in 5/36 controls [14%, 4 described as gastrointestinal stromal nodular tumors (GIST), and 1 as polyp] and in 5/18 acromegalic patients [28%, 2 GIST and 3 polyps]. In acromegaly, the calculated relative risk for all SB lesions was 1.69 [95%confidence interval (CI): 0.78-3.65], while the relative risk for SB polyps was 2.50 (95% CI: 1.23-5.07). The effective duration of active disease was longer in patients with positive than in those with negative VCE (112+/-89 vs 49+/-40 months, p=0.06). In conclusion, these preliminary results suggest that acromegalic patients might have a high risk of SB polyp development. VCE might be a useful adjunctive diagnostic tool in acromegaly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494714     DOI: 10.1007/BF03346495

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  37 in total

1.  Circulating insulin-like growth factor II and colorectal adenomas.

Authors:  A G Renehan; J E Painter; D O'Halloran; W S Atkin; C S Potten; S T O'Dwyer; S M Shalet
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

Review 2.  The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge.

Authors:  Rajaraman Durai; Wenxuan Yang; Sharmila Gupta; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Colorectal Dis       Date:  2005-01-14       Impact factor: 2.571

3.  Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels.

Authors:  Yutaka Matano; Toshihide Okada; Ayako Suzuki; Takashi Yoneda; Yoshiyun Takeda; Hiroshi Mabuchi
Journal:  Am J Gastroenterol       Date:  2005-05       Impact factor: 10.864

4.  Diagnosis and outcome of small bowel tumors found by capsule endoscopy: a three-center Australian experience.

Authors:  Adam A Bailey; Henry S Debinski; Mark N Appleyard; Matthew L Remedios; Judy E Hooper; Alissa J Walsh; Warwick S Selby
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

5.  Outcome of capsule endoscopy in determining indication and route for push-and-pull enteroscopy.

Authors:  G Gay; M Delvaux; I Fassler
Journal:  Endoscopy       Date:  2006-01       Impact factor: 10.093

6.  Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy.

Authors:  Massimo Terzolo; Giuseppe Reimondo; Maurizio Gasperi; Renato Cozzi; Rosario Pivonello; Giovanni Vitale; Alfredo Scillitani; Roberto Attanasio; Elisabetta Cecconi; Fulvia Daffara; Ezio Gaia; Ennio Martino; Gaetano Lombardi; Alberto Angeli; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2004-10-26       Impact factor: 5.958

7.  Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.

Authors:  M Peracchi; C Gebbia; G Basilisco; M Quatrini; C Tarantino; C Vescarelli; S Massironi; D Conte
Journal:  Eur J Endocrinol       Date:  2005-03       Impact factor: 6.664

Review 8.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

9.  The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients.

Authors:  Annamaria Colao; Rosario Pivonello; Renata S Auriemma; Mariano Galdiero; Diego Ferone; Francesco Minuto; Paolo Marzullo; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

10.  Mortality in acromegaly: a metaanalysis.

Authors:  O M Dekkers; N R Biermasz; A M Pereira; J A Romijn; J P Vandenbroucke
Journal:  J Clin Endocrinol Metab       Date:  2007-10-30       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.